AAAAAA

   
Results: 1-10 |
Results: 10
The frozen section yesterday and today: Pediatric solid tumors - Crucial issues
Authors: Fisher, JE Burger, PC Perlman, EJ Dickman, PS Parham, DM Savell, VH Hutchison, RE Paidas, CN Lev, ER
Citation: Je. Fisher et al., The frozen section yesterday and today: Pediatric solid tumors - Crucial issues, PEDIATR D P, 4(3), 2001, pp. 252-266
Methods to identify and characterize developmental neurotoxicity for humanhealth risk assessment. III: Pharmacokinetic and pharmacodynamic considerations
Authors: Dorman, DC Allen, SL Byczkowski, JZ Claudio, L Fisher, JE Fisher, JW Harry, GJ Li, AA Makris, SL Padilla, S Sultatos, LG Mileson, BE
Citation: Dc. Dorman et al., Methods to identify and characterize developmental neurotoxicity for humanhealth risk assessment. III: Pharmacokinetic and pharmacodynamic considerations, ENVIR H PER, 109, 2001, pp. 101-111
Lipoblastoma: better termed infantile lipoma?
Authors: O'Donnell, KA Caty, MG Allen, JE Fisher, JE
Citation: Ka. O'Donnell et al., Lipoblastoma: better termed infantile lipoma?, PEDIAT SURG, 16(5-6), 2000, pp. 458-461
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
Authors: Duggan, ME Duong, LT Fisher, JE Hamill, TG Hoffman, WF Huff, JR Ihle, NC Leu, CT Nagy, RM Perkins, JJ Rodan, SB Wesolowski, G Whitman, DB Zartman, AE Rodan, GA Hartman, GD
Citation: Me. Duggan et al., Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist, J MED CHEM, 43(20), 2000, pp. 3736-3745
In vivo effects of bisphosphonates on the osteoclast mevalonate pathway
Authors: Fisher, JE Rodan, GA Reszka, AA
Citation: Je. Fisher et al., In vivo effects of bisphosphonates on the osteoclast mevalonate pathway, ENDOCRINOL, 141(12), 2000, pp. 4793-4796
Patterns of MHR3 expression in the epidermis during a larval molt of the tobacco hornworm Manduca sexta
Authors: Langelan, RE Fisher, JE Hiruma, K Palli, SR Riddiford, LM
Citation: Re. Langelan et al., Patterns of MHR3 expression in the epidermis during a larval molt of the tobacco hornworm Manduca sexta, DEVELOP BIO, 227(2), 2000, pp. 481-494
The longitudinal study of surgical residents 1994-1396
Authors: Fisher, JE Friedmann, P
Citation: Je. Fisher et P. Friedmann, The longitudinal study of surgical residents 1994-1396, J AM COLL S, 188(6), 1999, pp. 676-677
Delayed myonecrosis in a leukemic patient with invasive group A streptococcal disease
Authors: Rotta, AT Grossi, M Fisher, JE Faden, H
Citation: At. Rotta et al., Delayed myonecrosis in a leukemic patient with invasive group A streptococcal disease, PEDIAT INF, 18(6), 1999, pp. 564-567
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
Authors: Fisher, JE Rogers, MJ Halasy, JM Luckman, SP Hughes, DE Masarachia, PJ Wesolowski, G Russell, RGG Rodan, GA Reszka, AA
Citation: Je. Fisher et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, P NAS US, 96(1), 1999, pp. 133-138
Toward uniform left-turn guidelines
Authors: Fisher, JE
Citation: Je. Fisher, Toward uniform left-turn guidelines, ITE J, 68(12), 1998, pp. 46
Risultati: 1-10 |